Immunotherapy has shown promise in many solid tumors including melanoma and non-
small cell lung cancer with an evolving role in breast cancer. Immunotherapy encompasses …

Immunotherapy is revolutionizing the management of multiple solid tumors, and early data
have revealed the clinical activity of programmed cell death-1/programmed death ligand-1 …

Immunooncology and its translation into the clinic represents a bridge between basic
research and clinical practice in cancer medicine. It benefits from an increased knowledge …

Breast cancer is the most commonly diagnosed cancer (estimated 2.3 million new cases in
2020) and the leading cause of cancer death (estimated 685,000 deaths in 2020) in women …

Simple Summary The role of the immune system in breast cancer has been debated for
decades. It is generally accepted that tumor-infiltrating lymphocytes are associated with …

Early diagnosis and treatment of breast cancer may account for the current improvement in
the mortality of breast cancer. However, achieving a complete 'cure'is the holy grail of cancer …

The prognostic value of tumor infiltrating lymphocytes in breast cancer has long been
recognized by histopathologists. These observations were reaffirmed by recent …

It is increasingly acknowledged that breast cancer can be an immunogenic disease.
Immunogenicity appears to differ between subtypes. For instance, in triple negative breast …

Immunotherapy for the treatment of breast cancer can be categorized as either (a) specific
stimulation of the immune system by active immunization with cancer vaccines or (b) passive …

Cancer remains a major health problem despite numerous new medical interventions that
have been introduced in recent years. One of the major choices for cancer therapy is so …